RetinalGenix Technologies (RTGN) Other Non-Current Assets (2024 - 2026)
RetinalGenix Technologies (RTGN) reported Other Non-Current Assets of $1995.0 for Q1 2026, little changed on a YoY basis from $1995.0 in Q1 2025, and little changed sequentially from $1995.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Other Non-Current Assets (2024 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 3 years of Other Non-Current Assets data on file, last reported at $1995.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $1995.0; the trailing twelve-month figure through Mar 2026 stood at $1995.0 (changed 0.0% YoY), and the FY2025 full-year result was $1995.0, changed 0.0% from the prior year.
- Other Non-Current Assets held at $1995.0 in Q1 2026, from $1995.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1995.0 in Q3 2024 to a low of $1995.0 in Q3 2024.
- A 3-year average of $1995.0 and a median of $1995.0 in 2024 frame the typical range for Other Non-Current Assets.
- Peak annual rise in Other Non-Current Assets reached 0.0% in 2025, while the deepest fall reached 0.0% in 2025.
- Tracing RTGN's Other Non-Current Assets over 3 years: stood at $1995.0 in 2024, then changed by 0.0% to $1995.0 in 2025, then changed by 0.0% to $1995.0 in 2026.
- Business Quant data shows RTGN's Other Non-Current Assets at $1995.0 in Q1 2026, $1995.0 in Q4 2025, and $1995.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 1,995.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,995.00 |
| Dec 31, 2025 | 1,995.00 |
| Sep 30, 2025 | 1,995.00 |
| Jun 30, 2025 | 1,995.00 |
| Mar 31, 2025 | 1,995.00 |
| Dec 31, 2024 | 1,995.00 |
| Sep 30, 2024 | 1,995.00 |